Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.08 USD | +1.38% | +8.35% | -35.96% |
May. 09 | Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | Stifel Raises Price Target on Disc Medicine to $73 From $71, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.96% | 904M | |
+51.56% | 55.7B | |
+41.08% | 39.91B | |
-5.91% | 39.57B | |
-5.56% | 28.16B | |
+15.72% | 26.3B | |
-19.74% | 18.94B | |
+31.53% | 12.17B | |
+26.51% | 12.12B | |
+1.50% | 12.12B |
- Stock Market
- Equities
- IRON Stock
- News Disc Medicine, Inc.
- Morgan Stanley Cuts Price Target on Disc Medicine to $40 From $75, Says Bitopertin Trial's Missed Secondary Endpoint Increases Uncertainty on Regulatory Path; Equalweight Kept